Involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty rats with metabolic syndrome

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Di Filippo, C ^a   Rossi, C ^a   Ferraro, B ^a   Maisto, R ^a   De Angelis, A ^a   Ferraraccio, F ^a   Rotondo, A ^a   D'Amico, M ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEASOME; PROTEASOME SUBUNIT 20S; PROTEASOME SUBUNIT 26S; TELMISARTAN; UBIQUITIN; UNCLASSIFIED DRUG; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DIASTOLIC DYSFUNCTION; ECHOGRAPHY; HEART CONTRACTION; HEART INFARCTION SIZE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART PERFORMANCE; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METABOLIC SYNDROME X; NONHUMAN; RAT; REPERFUSION INJURY; ZUCKER DIABETIC FATTY RAT; ANIMAL; IMMUNOLOGY; METABOLISM; MYOCARDIAL INFARCTION; ZUCKER RAT;

ANIMALS; BENZIMIDAZOLES; BENZOATES; MACROPHAGES; METABOLIC SYNDROME X; MYOCARDIAL INFARCTION; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, ZUCKER;

EID: 84904615192     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/972761     Document Type: Article

References (19)

1. Li L., Luo Z., Yu H., Feng X., Wang P., Chen J., Pu Y., Zhao Y., He H., Zhong J., Liu D., Zhu Z., Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-d activation. Diabetes 2013 62 3 762 774 10.2337/db12-0570 2-s2.0-84874443818
2. Rinaldi B., di Filippo C., Capuano A., Donniacuo M., Sodano L., Ferraraccio F., Rossi F., D'Amico M., Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in zucker diabetic fatty rats with metabolic syndrome. Diabetes, Obesity and Metabolism 2012 14 4 320 328 10.1111/j.1463-1326.2011.01527.x 2-s2.0-84858006294
3. Marfella R., di Filippo C., Portoghese M., Barbieri M., Ferraraccio F., Siniscalchi M., Cacciapuoti F., Rossi F., D'Amico M., Paolisso G., Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. Journal of Lipid Research 2009 50 11 2314 2323 10.1194/jlr.P900032- JLR200 2-s2.0-70350349875
4. Marfella R., Filippo C. D., Portoghese M., Siniscalchi M., Martis S., Ferraraccio F., Guastafierro S., Nicoletti G., Barbieri M., Coppola A., Rossi F., Paolisso G., D'Amico M., The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovascular Pathology 2009 18 6 332 345 10.1016/j.carpath.2008.09. 008 2-s2.0-70350566100
5. Kurihara T., Ozawa Y., Nagai N., Shinoda K., Noda K., Imamura Y., Tsubota K., Okano H., Oike Y., Ishida S., Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008 57 8 2191 2198 10.2337/db07-1281 2-s2.0-50949116171
6. Mostarda C., Rodrigues B., Vane M., Moreira E. D., Rosa K., Moraes-Silva I. C., Lacchini S., Casarini D. E., De Angelis K., Irigoyen M. C., Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clinical and Experimental Pharmacology and Physiology 2010 37 4 447 452 10.1111/j.1440-1681.2009.05327.x 2-s2.0-77949896710
7. de Vries H. E., Buchner B., van Berkel T. J. C., Kuiper J., Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 638 645 10.1161/01.ATV.19.3.638 2-s2.0-0033049512 (Pubitemid 29135166)
8. Marfella R., D'Amico M., di Filippo C., Baldi A., Siniscalchi M., Sasso F. C., Portoghese M., Carbonara O., Crescenzi B., Sangiuolo P., Nicoletti G. F., Rossiello R., Ferraraccio F., Cacciapuoti F., Verza M., Coppola L., Rossi F., Paolisso G., Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. Journal of the American College of Cardiology 2006 47 12 2444 2455 10.1016/j.jacc.2006.01.073 2-s2.0-33744978316 (Pubitemid 43866361)
9. Yu X., Kem D. C., Proteasome inhibition during myocardial infarction. Cardiovascular Research 2010 85 2 312 320 10.1093/cvr/cvp309 2-s2.0-72949089694
10. Razeghi P., Baskin K. K., Sharma S., Young M. E., Stepkowski S., Faadiel Essop M., Taegtmeyer H., Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochemical and Biophysical Research Communications 2006 342 2 361 364 10.1016/j.bbrc.2006.01.163 2-s2.0-33344473389 (Pubitemid 43289002)
11. Mearini G., Schlossarek S., Willis M. S., Carrier L., The ubiquitin-proteasome system in cardiac dysfunction. Biochimica et Biophysica Acta 2008 1782 12 749 763 10.1016/j.bbadis.2008.06.009 2-s2.0-56949095293
12. Marfella R., D'Amico M., di Filippo C., Siniscalchi M., Sasso F. C., Ferraraccio F., Rossi F., Paolisso G., The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes. Cardiovascular Diabetology 2007 6, article 35 10.1186/1475-2840-6-35 2-s2.0-37749024417
13. Yang M., Zheng J., Miao Y., Wang Y., Cui W., Guo J., Qiu S., Han Y., Jia L., Li H., Cheng J., Du J., Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arteriosclerosis, Thrombosis and Vascular Biology 2012 32 7 1675 1686 10.1161/ATVBAHA.112.248732 2-s2.0-84865297181
14. Rigamonti E., Zordan P., Sciorati C., Rovere-Querini P., Brunelli S., Macrophage plasticity in skeletal muscle repair. BioMed Research International 2014 2014 9 560629 10.1155/2014/560629
15. Davis M. J., Tsang T. M., Qiu Y., Dayrit J. K., Freij J. B., Huffnagle G. B., Olszewski M. A., Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. mBio 2013 4 3 e00264 10.1128/mBio.00264-13 2-s2.0-84879562515
16. Jadhav A., Tiwari S., Lee P., Ndisang J. F., The heme oxygenase system selectively enhances the anti-inflammatory macrophage-M2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats. Journal of Pharmacology and Experimental Therapeutics 2013 345 2 239 249 10.1124/jpet.112.200808 2-s2.0-84876569854
17. Brown M. A., Hural J., Functions of IL-4 and control of its expression. Critical Reviews in Immunology 1997 17 1 1 32 10.1615/CritRevImmunol.v17.i1.10 2-s2.0-0031014560 (Pubitemid 27068806)
18. Lee H., Lee I. S., Choue R., Obesity, inflammation and diet. Pediatric Gastroenterology, Hepatology & Nutrition 2013 16 143 152
19. Ren M., Guo Q., Guo L., Lenz M., Qian F., Koenen R. R., Xu H., Schilling A. B., Weber C., Ye R. D., Dinner A. R., Tang W., Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. The EMBO Journal 2010 29 23 3952 3966 10.1038/emboj.2010.256 2-s2.0-78649694743